| Literature DB >> 27356049 |
Robert Weissmann1, Tim Kacprowski, Michel Peper, Jennifer Esche, Lars R Jensen, Laura van Diepen, Matthias Port, Andreas W Kuss, Harry Scherthan.
Abstract
Ionizing radiation is known to induce genomic lesions, such as DNA double strand breaks, whose repair can lead to mutations that can modulate cellular and organismal fate. Soon after radiation exposure, cells induce transcriptional changes and alterations of cell cycle programs to respond to the received DNA damage. Radiation-induced mutations occur through misrepair in a stochastic manner and increase the risk of developing cancers years after the incident, especially after high dose radiation exposures. Here, the authors analyzed the transcriptomic response of primary human gingival fibroblasts exposed to increasing doses of acute high dose-rate x rays. In the dataset obtained after 0.5 and 5 Gy x-ray exposures and two different repair intervals (0.5 h and 16 h), the authors discovered several radiation-induced fusion transcripts in conjunction with dose-dependent gene expression changes involving a total of 3,383 genes. Principal component analysis of repeated experiments revealed that the duration of the post-exposure repair intervals had a stronger impact than irradiation dose. Subsequent overrepresentation analyses showed a number of KEGG gene sets and WikiPathways, including pathways known to relate to radioresistance in fibroblasts (Wnt, integrin signaling). Moreover, a significant radiation-induced modulation of microRNA targets was detected. The data sets on IR-induced transcriptomic alterations in primary gingival fibroblasts will facilitate genomic comparisons in various genotoxic exposure scenarios.Entities:
Mesh:
Year: 2016 PMID: 27356049 PMCID: PMC4936435 DOI: 10.1097/HP.0000000000000419
Source DB: PubMed Journal: Health Phys ISSN: 0017-9078 Impact factor: 1.316
Radiation-induced fusion transcripts in comparison to untreated cells.a
Fig. 1Venn diagram [developed using Venny (Oliveros 2015)] showing the numbers of genes with dose-dependent expression increase 0.5 h (a) and 16 h (c) after IR, the numbers of genes with dose-dependent expression decrease 0.5 h (b) and 16 h (d) after IR. An explicit list of the genes with altered expression is given in Tables Supplemental Digital Content 2–5, http://links.lww.com/HP/A54, http://links.lww.com/HP/A55, http://links.lww.com/HP/A56.
Fig. 2Association of principal components to sample properties. dT - repair interval; Gray - radiation dose in Gy; Experiment - individual experiments; PCi - ith principal component. Blue shading indicates significant association between a PC and a sample parameter. Numbers in cells represent the adjusted R-squared value for the linear regression models.
Fig. 3Principal component analysis results. (a) Importance of principal components (PC). The grey bars depict the cumulative explained variance in the data when considering PC1 to PCi; e.g., the third bar, corresponding to PC3, shows the variance in the data explainable by PC1, PC2, and PC3 together. The blue dots indicate the Eigenvalues of the respective PCs. The Eigenvalues are a measure for how far the data spread along the given PC. This information is closely related to the explained variance per PC (the more variance is explained by the PC, the further the data are spread along it). (b) Scatter plots of the samples projected onto PC1 vs. PC5 (left) and PC1 vs. PC10 (right). The shape of the symbol corresponds to the individual experiments. The time between irradiation and sequencing is indicated by the size of the symbols (larger symbol, longer time). The color shows the radiation dose (black: 0 gray, red: 0.5 gray, green: 5 gray, blue: 10 gray). The sorting of symbols along the x-axis visualizes the strong association of PC1 to the individual experiments. Similarly, PC5 sorts the symbols according to their size, indicating its association to the time between irradiation and sequencing. PC10's association to the radiation dosage becomes evident by the sorting of the symbols according to their colors.
Targets of the transcription factor p53.